ClinicalTrials.gg
Drug

Mecasermin clinical trials

Also written Increlex and insulin-like growth factor I.

studies test it
34
open now
1
in phase 3
8
first study started
1991

How each study uses mecasermin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the mecasermin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Aug 2005 · INCRELEX · BLA 021839 (FDA, Drugs@FDA)
European Union
2 Aug 2007 · Increlex · EMEA/H/C/000704 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

rhIGF-1
7
mecasermin
6
IGF-1
3
Recombinant Human IGF-1
2

Brand

Increlex
13

Other names

insulin-like growth factor I
4
Insulin-Like Growth Factor 1
1

In one entry with another drug

Given together, or one or the other

rhIGF-1/rhIGFBP-3
2

Studies by the year they started

33 studies that test it; most in 2011 (7)

Studies that test mecasermin, by start year
YearStudies
19911
19952
19971
19981
20001
20041
20052
20073
20084
20091
20102
20117
20121
20132
20141
20152
20191

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
9
Phase 2
19
Phase 3
8
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 27

Ipsen (5) · Massachusetts General Hospital (4) · Children's Hospital Medical Center, Cincinnati (2) · Icahn School of Medicine at Mount Sinai (2) · Boston Children's Hospital (2) · Children's Hospital of Philadelphia (2) · Bispebjerg Hospital (2) · The University of Texas Medical Branch, Galveston (1)

Often tested with

Tested in the same studies.

Rinfabate (2) · Insulin (1) · Oxandrolone (1) · Propranolol (1) · Growth Hormone (1) · Insulin-Like Growth Factor Binding Protein 3 (1) · Itraconazole (1) · Estradiol (1)

Studies

Open first, then newest update. How each study uses mecasermin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 34

See all 34 studies that test mecasermin →

Codes

What other systems call mecasermin · ClinicalTrials.gg INT000380

  • MeSH (NLM) C000604197mecaserminConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7GR9I2683OMECASERMINConfirmed FDA, NLM, Wikidata
  • RxNorm 274403Confirmed FDA, Wikidata
  • Wikidata Q6804390mecaserminConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2262MecaserminConfirmed FDA, Wikidata
  • DrugBank DB01277One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.